AUSTRALIAN TELETRIAL PROGRAM REACHES SIGNIFICANT MILESTONES IN TRIALS AND PARTICIPANTS From origins in Townsville to being national program across multiple disease states and populations
Filmed in Brisbane & Townsville, Queensland and Darwin, Northern Territory | November 2024
Launched in 2022, the Australian Teletrial Program is an initiative designed to improve access to clinical trials for people living in regional and remote areas of Australia. It uses telemedicine and digital technologies to enable patients to participate in clinical trials without needing to travel long distances to major metropolitan centres, which can often be a barrier to participation for those in rural and isolated locations.
The program connects patients with researchers, medical professionals, and trial coordinators via video consultations and telehealth tools. This allows patients to receive treatment and follow-up care from their local healthcare providers, while still participating in high-quality clinical research.
Key Features of the Australian Teletrial Program:
- Remote Access to Trials: It facilitates the inclusion of patients from regional and remote areas who would otherwise have difficulty accessing clinical trials due to distance or travel constraints.
- Collaboration: The program involves partnerships between local healthcare providers, hospitals, research institutions, and trial sponsors. This collaborative model ensures that patients receive the best care and support throughout the trial process.
- Digital Health Technologies: Telehealth technologies, such as video conferencing, remote monitoring, and digital data collection, are used to manage patient care and ensure compliance with trial protocols.
- Widening Participation: It aims to diversify and increase the representation of regional and rural populations in clinical trials, which is important for trial results to include the broader population.
The Teletrial Program is part of a broader effort to improve the inclusivity and accessibility of medical research across Australia, ensuring that individuals, regardless of their location, have the opportunity to participate in cutting-edge clinical trials.
Recently Australian Health Journal met with Kaye Hewson, Director, Australian Teletrials Program, who spoke about the program’s recent achievements:
- Being a proven program outside of oncology, with clinical specialties such as respiratory, cardiac, diabetes, sexual health, mental health filling a gap in service and equity.
- In regional, rural and remote places, with adults and paediatrics involved in the program, a higher than national average participation rate of clinical trials by First Nations peoples in satellite locations.
- Savings of time, money and distance for those patients to satellite sites.
- Having over a thousand participants in teletrials across the six jurisdictions.
- Established collaborative and supportive mechanism and network around education and training.
Australian Health Journal also spoke with Melanie Poxton, Assistant Director of Nursing at the program’s Queensland Regional Clinical Trials Coordinating Centre (QRCCC) in Townsville University Hospital, North Queensland and Heather Parker, the Northern Territory Australian Teletrial Program Manager with NT Health.
Produced in collaboration with the Australian Teletrial Program.
-
Implementing improvements in referral management and demand
Nalani Cox joined Gold Coast Health in 2019 as a Nurse Manager focused on improving referral management processes within the outpatient environment through the implementation of the Clinical Prioritisation Criteria. This work became a focus point for the organisation in 2020 when Nalani led an organisational wide change project introducing Smart Referrals, Refer Your Patient website and HealthPathways which has culminated in her position as the ADON of the Referral Strategy and Performance Department.
-
Health Minister appoints Chair to National One Stop Shop Program
The Australian Government has appointed Emeritus Professor Ian Chubb AC, FAA FTSE to lead key reforms as Chair of the Inter-Governmental Policy Reform Group (IGPRG) for health and medical research, including clinical trials.
Minister for Health and Aged Care, The Hon Mark Butler MP on the selection and appointment said, “Professor Chubb has dedicated his career to improving health and medical research and education in this county and I am pleased he has agreed to share his knowledge and experience through the IGPRG.
-
Misinformation impacts routine vaccines
More significant changes in recent years have been health-related misinformation eroding trust in healthcare professionals, leading to people seeking alternative treatments or avoiding medical advice altogether. This can make it more difficult for healthcare professionals to provide effective treatment and care.
Recent vaccines delivered as part of the COVID-19 response, are having a consequential impact on the uptake of routine vaccines.
Australian Health Journal spoke with Dr Paul Griffin, an Infectious Diseases Physician and Microbiologist at Mater Health, and who has been involved in over 150 clinical trials in the field of infectious disease.
Paul talks about the importance of having reputable sources of information that can used to encourage people to understand what is involved in clinical trials and the roles of vaccines.
